Comparative study on hypotensive effect by administration timing of L/N-type calcium channel blocker cilnidipine in chronic kidney disease patients
Not Applicable
Recruiting
- Conditions
- Hypertension with chronic kidney disease
- Registration Number
- JPRN-UMIN000014108
- Lead Sponsor
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Dialysis patients. 2.Clinical blood pressure is 180/100mmHg or more in antihypertensive treatment. 3.Patients already received cilnidipine. 4.Patients with a history of hypersensitivity to cilnidipine. 5.Pregnant women or women who are suspect of pregnancy. 6.Patients judged as inappropriate for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ambulatory blood pressure monitoring (ABPM)
- Secondary Outcome Measures
Name Time Method 1)BW, obesity, abdominal circumference. 2)Clinical blood pressure 3)Renal function 4)Cardiovascular function(Echocardiographic study, AI, ABI/baPWV), CAVI, Sympathetic nerve activity) 5)Blood examination 6)Lipid metabolism 7)Inflammatory marker